Hearing entitled “Legislative Proposals to Enhance Capital Formation and Reduce Regulatory Burdens”
Wednesday, April 29, 2015 2:00 PM in HVC-210 Capitol Visitor Center Capital Markets and Government Sponsored Enterprises
H.R. 432, the “Small Business Investment Company Advisers Relief Act of 2015”
H.R. 686, the “Small Business Mergers, Acquisitions, Sales, and Brokerage Simplification Act of 2015”
H.R. 1317, a bill to amend the Commodity Exchange Act and the Securities Exchange Act of 1934 to specify how clearing requirements apply to certain affiliate transactions, and for other purposes
H.R. 1334, the “Holding Company Registration Threshold Equalization Act of 2015”
H.R. 1525, the “Disclosure Modernization and Simplification Act of 2015”
H.R. 1675, the “Encouraging Employee Ownership Act of 2015”
H.R. 1723, the “Small Business Freedom and Growth Act of 2015”
H.R. 1839, the “Reforming Access for Investments in Startup Enterprises Act of 2015”
H.R. 1847, the “Swap Data Repository and Clearinghouse Indemnification Correction Act”
H.R. 1965, the “Small Company Disclosure Simplification Act”
H.R. 1975, a bill to amend the Securities Exchange Act of 1934 to require the Securities Exchange Commission to refund or credit excess payments made to the Commission
H.R. ____, the “Improving Access to Capital for Emerging Growth Companies Act”
Witness List
Mr. Thomas C. Deas, Vice President and Treasurer, FMC Corporation, on behalf of the Coalition for Derivatives End-Users (TTF)
Ms. Gayle Hughes, Partner, Merion Investment Partners, on behalf of the Small Business Investor Alliance (TTF)
Mr. Shane Kovacs, Executive Vice President, Chief Financial Officer and Head of Corporate Development, PTC Therapeutics, Inc., on behalf of the Biotechnology Industry Organization (TTF)
Mr. Thomas Quaadman, Vice President, Center for Capital Markets Competitiveness, U.S. Chamber of Commerce (TTF)
